JP Morgan Chase’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.63B | Sell |
20,820,621
-13,171,789
| -39% | -$1.74B | 0.15% | 140 |
|
|
2026
Q1 | $4.63B | Buy |
33,992,410
+10,956,647
| +48% | +$1.53B | 0.3% | 69 |
|
|
2025
Q4 | $2.83B | Buy |
23,035,763
+1,871,128
| +9% | +$227M | 0.18% | 119 |
|
|
2025
Q3 | $2.35B | Buy |
21,164,635
+2,085,044
| +11% | +$237M | 0.14% | 149 |
|
|
2025
Q2 | $2.12B | Buy |
19,079,591
+7,999,385
| +72% | +$851M | 0.14% | 146 |
|
|
2025
Q1 | $1.24B | Buy |
11,080,206
+5,470,737
| +98% | +$564M | 0.09% | 212 |
|
|
2024
Q4 | $518M | Sell |
5,609,469
-1,054,555
| -16% | -$95M | 0.04% | 374 |
|
|
2024
Q3 | $559M | Sell |
6,664,024
-363,665
| -5% | -$27.7M | 0.04% | 360 |
|
|
2024
Q2 | $482M | Buy |
7,027,689
+413,294
| +6% | +$27.6M | 0.04% | 378 |
|
|
2024
Q1 | $485M | Buy |
6,614,395
+1,012,015
| +18% | +$77.8M | 0.04% | 390 |
|
|
2023
Q4 | $454M | Buy |
5,602,380
+147,034
| +3% | +$11.4M | 0.04% | 379 |
|
|
2023
Q3 | $409M | Buy |
5,455,346
+911,308
| +20% | +$70.1M | 0.05% | 356 |
|
|
2023
Q2 | $350M | Buy |
4,544,038
+62,515
| +1% | +$4.99M | 0.04% | 403 |
|
|
2023
Q1 | $372M | Sell |
4,481,523
-419,126
| -9% | -$34.7M | 0.05% | 368 |
|
|
2022
Q4 | $421M | Sell |
4,900,649
-129,381
| -3% | -$10.2M | 0.06% | 325 |
|
|
2022
Q3 | $310M | Sell |
5,030,030
-302,470
| -6% | -$19.1M | 0.04% | 375 |
|
|
2022
Q2 | $330M | Sell |
5,332,500
-358,190
| -6% | -$22.2M | 0.05% | 370 |
|
|
2022
Q1 | $338M | Buy |
5,690,690
+2,524,557
| +80% | +$161M | 0.04% | 405 |
|
|
2021
Q4 | $230M | Buy |
3,166,133
+792,003
| +33% | +$54.6M | 0.03% | 525 |
|
|
2021
Q3 | $166M | Sell |
2,374,130
-1,102,936
| -32% | -$77.5M | 0.02% | 633 |
|
|
2021
Q2 | $239M | Sell |
3,477,066
-118,258
| -3% | -$7.9M | 0.03% | 546 |
|
|
2021
Q1 | $232M | Sell |
3,595,324
-85,479
| -2% | -$5.51M | 0.03% | 526 |
|
|
2020
Q4 | $214M | Buy |
3,680,803
+912,216
| +33% | +$55M | 0.03% | 507 |
|
|
2020
Q3 | $172M | Sell |
2,768,587
-5,061
| -0.2% | -$351K | 0.03% | 521 |
|
|
2020
Q2 | $213M | Sell |
2,773,648
-4,322,198
| -61% | -$331M | 0.04% | 422 |
|
|
2020
Q1 | $530M | Buy |
7,095,846
+843,436
| +13% | +$58.3M | 0.12% | 175 |
|
|
2019
Q4 | $406M | Sell |
6,252,410
-714,261
| -10% | -$46.5M | 0.08% | 272 |
|
|
2019
Q3 | $442M | Sell |
6,966,671
-1,272,831
| -15% | -$83.2M | 0.09% | 253 |
|
|
2019
Q2 | $553M | Sell |
8,239,502
-3,283,372
| -28% | -$216M | 0.11% | 199 |
|
|
2019
Q1 | $749M | Sell |
11,522,874
-2,386,390
| -17% | -$159M | 0.15% | 143 |
|
|
2018
Q4 | $870M | Sell |
13,909,264
-2,250,117
| -14% | -$157M | 0.2% | 110 |
|
|
2018
Q3 | $1.25B | Buy |
16,159,381
+975,233
| +6% | +$73.7M | 0.24% | 87 |
|
|
2018
Q2 | $1.08B | Buy |
15,184,148
+595,392
| +4% | +$42M | 0.22% | 95 |
|
|
2018
Q1 | $1.1B | Buy |
14,588,756
+2,685,891
| +23% | +$214M | 0.24% | 85 |
|
|
2017
Q4 | $853M | Sell |
11,902,865
-1,124,743
| -9% | -$85.4M | 0.18% | 121 |
|
|
2017
Q3 | $1.05B | Sell |
13,027,608
-183,513
| -1% | -$14M | 0.23% | 86 |
|
|
2017
Q2 | $935M | Buy |
13,211,121
+291,173
| +2% | +$19.4M | 0.21% | 93 |
|
|
2017
Q1 | $878M | Sell |
12,919,948
-8,642,440
| -40% | -$608M | 0.2% | 102 |
|
|
2016
Q4 | $1.55B | Sell |
21,562,388
-2,806,343
| -12% | -$209M | 0.37% | 46 |
|
|
2016
Q3 | $1.93B | Sell |
24,368,731
-6,888,086
| -22% | -$560M | 0.47% | 31 |
|
|
2016
Q2 | $2.61B | Buy |
31,256,817
+1,164,741
| +4% | +$103M | 0.65% | 20 |
|
|
2016
Q1 | $2.76B | Buy |
30,092,076
+4,527,050
| +18% | +$408M | 0.71% | 16 |
|
|
2015
Q4 | $2.59B | Buy |
25,565,026
+1,577,828
| +7% | +$164M | 0.65% | 18 |
|
|
2015
Q3 | $2.36B | Sell |
23,987,198
-2,594,117
| -10% | -$288M | 0.63% | 21 |
|
|
2015
Q2 | $3.11B | Buy |
26,581,315
+7,086,710
| +36% | +$774M | 0.73% | 13 |
|
|
2015
Q1 | $1.91B | Sell |
19,494,605
-2,694,955
| -12% | -$274M | 0.44% | 40 |
|
|
2014
Q4 | $2.09B | Buy |
22,189,560
+338,704
| +2% | +$35M | 0.48% | 30 |
|
|
2014
Q3 | $2.33B | Buy |
21,850,856
+468,282
| +2% | +$45.9M | 0.55% | 27 |
|
|
2014
Q2 | $1.77B | Sell |
21,382,574
-1,140,807
| -5% | -$88.8M | 0.45% | 35 |
|
|
2014
Q1 | $1.6B | Sell |
22,523,381
-691,192
| -3% | -$54.2M | 0.44% | 40 |
|
|
2013
Q4 | $1.74B | Buy |
23,214,573
+2,255,252
| +11% | +$157M | 0.49% | 34 |
|
|
2013
Q3 | $1.32B | Buy |
20,959,321
+1,752,590
| +9% | +$105M | 0.39% | 46 |
|
|
2013
Q2 | $985M | Buy |
+19,206,731
| New | +$1B | 0.31% | 64 |
|
Other funds holding GILD
JP Morgan Chase's GILD Position: Q2 2026 in Review
JP Morgan Chase reduced its Gilead Sciences (GILD) stake by 39% in Q2 2026, selling an estimated $1.74B and leaving 20,820,621 shares worth $2.63B. The position accounts for 0.15% of the portfolio, ranked #140.
JP Morgan Chase first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.63B in Q1 2026. 2,261 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- JP Morgan Chase held 20,820,621 shares of Gilead Sciences worth $2.63B as of Q2 2026.
- JP Morgan Chase sold 13,171,789 Gilead Sciences shares in Q2 2026, an estimated $1.74B.
- Gilead Sciences made up 0.15% of JP Morgan Chase's portfolio in Q2 2026, its #140 holding.
- JP Morgan Chase first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Gilead Sciences position peaked at $4.63B in Q1 2026.
- 2,261 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.